Closed
SectorHealthcare
36.08 -2.04
24h
Min
35.78
Max
36.35
Income | -403M 30M |
---|---|
Sales | 10M 579M |
P/E Sector Avg | 15.712 35.733 |
EPS | 1.06 |
Dividend yield | 2.41 |
Profit margin | 5.215 |
EBITDA | -375M 159M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +20.88% upside |
Dividend yield Sector Avg | 2.41% 3.13% |
---|---|
Next Dividend date | 10 wrz 2025 |
Next Ex Dividend date | 14 lis 2025 |
Market Cap | -315M 21B |
---|---|
Previous open | 38.12 |
Previous close | 36.08 |
By Acuity
50%
50%
176 / 371 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 43.6 USD 20.88%
High 55 USD
Low 37 USD
Based on 5 Wall Street analysts offering 12 month price targets forRoyalty Pharma PLC (Class A) - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$